Proteins from CFPS reactions were strep-tag affinity purified, separated by SDS-PAGE and visualized by Coomassie blue staining. sfGFP-S2TAG produced by CFPS in the absence and presence of the Sep-OTS (lanes 1-2) and wild-type sfGFP (lane 3) are the same molecular weight. Production of low-level sfGFP in absence of the Sep-OTS due to near-cognate misincorporation of amino acids also produces full-length protein (lane 1). BSA standards (0.1, 0.25, 0.5, 1.0 and 2.0 µg) were analyzed on the same gel to assist with the quantitation of sfGFP (lanes 5-9).
Supplementary Figure 7. Validation of MEK1 biosynthesis via Western blot.
Western blot analysis of unphosphorylated MEK1 (MEK1-SS), singly (MEK1-S P S, MEK1-S P S), and doubly phosphorylated MEK1 (MEK1-S P S P ) variants. Equal volumes of affinity purified MEK kinases containing activation loop serines (S) or phosphoserines (S P ) at positions 218/222 were probed with an anti-6His antibody for total protein and phospho-specific MEK1 antibody (MEK1-S P S P ) respectively. Our data indicate that the anti-phos-MEK1 antibody (which binds MEK1-S P S P ) also binds MEK1-SS P , but not MEK1-S P S. Fig. 3b ). Time course study for the production of phospho-ERK upon addition of (a) MEK1-SS, (b) MEK1-S P S, (c) MEK1-SS P , and (d) MEK1-S P S P . MEK1 kinase activity was measured at 0.5 min, 1 min, 2 min, 5 min, 10 min, and 30 min time points using kinase dead ERK2 as a substrate. (e) Total ERK was also assessed. Supplementary Table 1 : Identification of N-terminal peptides from sfGFPs reporting incorporation of amino acids at positions S2 or E17 of sfGFP-S2TAG and sfGFP-E17TAG. All peptides are reported with a FDR cut-off of 1% and a minimum delta score of 5. Amino acids incorporated at TAG are in red. Peptides reporting skipping at TAG are in bold. Peptides reporting incorporation of K or R are marked with (K/R)* indicating that the amino acid K or R was cleaved off during tryptic digestion. Abbreviations: (de) deamidation, (ox) oxidation, (ph) phosphorylation. Bacterial cell pellets were stored at -80°C until extract preparation.
Supplementary Figure 8. Uncropped Western blots for assessing activity of phospho-MEK1 variants (from main text

Supplementary Tables
CFPS extract preparation
Cell pellets were thawed on ice and resuspended in ice cold S30 buffer using a cell weight to buffer ratio of 1.0g wet cell mass to 0.8ml S30 buffer. Cells were lysed on ice by sonication with a model Q125 sonicator (QSonica LLC, Newtown, CT). The lysis program consisted of three 45s bursts performed at 50% amplitude and 59s pause between subsequent bursts. The total deposited energy of approximately 900 Joules 3 . Lysate was supplemented with an additional 2mM Dithiothreitol (DTT) and cell debris was removed with a 10min spin performed at 12,000 x g at 4°C. The clarified cell extract was incubated for 1h at 37°C while shaking at 220 RPM and insoluble material was removed by centrifugation performed at 12,000 x g for 30min at 4°C. The supernatant was flash-frozen in liquid nitrogen and stored at -80°C until use for CFPS.
Protein quantification of sfGFP and MEK1
Expression of active sfGFP proteins in CFPS extracts was quantified by fluorescence spectroscopy. Briefly, CFPS reactions were diluted 50x with 50mM HEPES buffer pH 7. Total MEK1 protein production was quantified by monitoring the incorporation of radioactive 14 Cleucine into proteins following a protocol by Swartz and colleagues 5, 6 . Briefly, CFPS reactions were split evenly and deposited onto two 3 MM filter papers (Whatman) and either washed with 5% trichloroacetic acidic acid or dried without washing (untreated sample). Filters were dried for 1h under a heat lamp and radioactivity was measured by liquid scintillation counting on a MicroBeta2 instrument (PerkinElmer, Waltham, MA) and reported as counts per minute (cpm).
The molecular weight and number of leucine residues in MEK1 was calculated with ProtParam 
Expression of kinase inactive human ERK2 (K54R)
BL21(DE3) cells were transformed with the pET15-ERK2 plasmid of kinase inactive human ERK2 (K54R) and the culture was grown at 37°C, 230 RPM to an OD 600 of 0.8AU in LB media supplemented with 0.08% glucose, and 100μg/ml ampicillin. Protein expression was then induced with 1mM IPTG, and protein expression proceeded for ~20h at 20°C and 230 RPM.
Cells were pelleted (10 min at 4000 x g at 4°C) and the cell pellet was frozen for at least 1 h at -80°C. The cell pellet was briefly thawed in a 37°C water bath followed by resuspension in 5ml of ice-cold bacterial lysis buffer (50mM Tris-HCl pH 7.4, 500mM NaCl, 0.5mM EDTA, 0.5mM EGTA, 1mM DTT, 1mg/ml lysozyme, 50mM NaF, 1mM NaVO 4 , 10% glycerol, complete mini-EDTA-free protease inhibitor cocktail tablets) and incubated on ice for 30min, followed by sonication. The lysates were centrifuged at 22,000 x g for 15min at 4°C. The clarified lysate was purified by Ni-affinity chromatography with 200μl Ni-NTA agarose resin (Qiagen Valencia, CA) using Pierce spin columns (Thermo Scientific Waltham, MA). The resin was equilibrated with 5ml of Ni-NTA equilibration buffer (50mM Tris-HCl pH=7.4, 500mM NaCl, 0.5mM EDTA, 0.5mM EGTA, 1mM DTT, 50mM NaF, 1mM NaVO 4 , 10% glycerol). The clarified lysate was loaded onto the column via syringe. The column was then washed once with 10ml of Ni-NTA wash buffer (50mM Tris-HCl pH=7.4, 500mM NaCl, 0.5mM EDTA, 0.5mM EGTA, 1mM DTT, 50mM NaF, 1mM NaVO 4 , 10% glycerol, 20mM imidazole). Protein was eluted using Ni-NTA elution buffer (50mM Tris-HCl pH 7.4, 500mM NaCl, 0.5mM EDTA, 0.5mM EGTA, 1mM DTT, 50mM NaF, 1mM NaVO 4 , 10% glycerol, 250mM imidazole) and 400μl elutions were collected in 1.5ml
Eppendorf tubes. Eluted protein fractions were analyzed by SDS-PAGE and fractions containing the target protein were pooled and buffer-exchanged into the protein storage buffer (50mM TrisHCl pH=7.4, 150mM NaCl, 1mM DTT, 20% glycerol) using 0.5 ml 10kDa MWCO ultra centrifugal filters Amicon (Millipore Billerica, MA) and the protein was stored at −20°C. The protein concentration was quantified by UV absorbance spectroscopy at 280nm and by comparing known quantities of BSA standards (Pierce, Rockford, lL) on a coomassie stained SDS-PAGE gel.
Cloning pY71-sfGFP was previously described 4 . S2TAG sfGFP was constructed from pY71-sfGFP using inverse PCR with Primers 1 & 2 (Supplementary Table 4 ). The E17TAG mutations were made in the pY71-sfGFP and pY71-S2TAG sfGFP by site-directed mutagenesis using Primers 3 & 4
(Supplementary Table 4 ).
The gene for MBP-MEK1 S218/S222 was digested from the previously described pCG-MBP-MEK1 SS plasmid 2 using XbaI blunt/HindIII restriction enzymes and subcloned into pCRT7 NT Topo tetR pLtetO that had been digested with KpnI blunt /HindIII restriction enzymes. Blunting was performed using quick blunting enzyme (New England Biolabs). The gene for the MBP-MEK1 S218TAG/S222E was subcloned from the previously reported pCG-MBPMEK1XE plasmid 2 using XbaI/HindIII restrictions sites. The fragment containing MBP-MEK1 was blunted and treated with calf intestinal alkaline phosphatase (CIP, NEB). The fragment between the KpnI/HindIII sites in pCRT7 NT Topo tetR pLtetO was removed and the restriction sites were blunted. The MBP-MEK1 S218TAG/S222E fragment was ligated into the blunted KpnI/HindIII sites of the pCRT7 NT Topo tetR pLtetO plasmid. S222E was then mutated to TAG by sitedirected mutagenesis using primers P5 & P6 to create MBP-MEK1 S218TAG/S222TAG. For the experiments described here, the MEK1 S218/S222 and S218TAG/S222TAG genes were further subcloned by digesting both MEK1 fragment with NdeI-SalI cloning between the same restriction sites in the previously described pY71 plasmid 4 . MEK1 S218TAG/S222 and S218/S222TAG were created from MEK1 S218TAG/S222TAG using site-directed mutagenesis with primers P7 & P8 and P9 & P10, respectively. We also constructed Strep-tag MEK1
variants. For these, the C-terminal 6xHis-tag for MEK1 S218/S222, MEK1 S218/S222TAG, and MEK1 S218TAG/S222TAG was replaced with a C-terminal Strep-tag via inverse PCR using primers P13 & P14. The previously described pET15-ERK2 plasmid 2 was used to construct a K54R mutation in ERK2 which inactivates the kinase. Lys54 was mutated by site-directed mutagenesis using primers P11 & P12. The construction of the SepOTS plasmid (OTS1.5) was previously described by Aerni 
Digestion of MEK1 protein samples
The following MEK1 constructs were analyzed by mass spectrometry: MEK1 SS (S218S/S222S) and MEK1 S 
Label-free quantitation of amino acid incorporation
Label-free quantitation of amino acid incorporation for sfGFP was performed by spectra counting ( Supplementary Fig. 2 , Supplementary Table 2 ) and using MS1 intensity based quantitation (Supplementary Table 3 ). The MS1 peak intensities for each charge state of all peptides reported in Supplementary Table 1 were determined with Skyline software 9 v. Table 3 , Supplementary Figs. 3 and 4 ).
